Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India-Reference-Cited by-同舟云学术

Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India

Published:2023-04-08 Issue:3 Volume:29 Page:931-934
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Bansal Shweta¹,Donners Anouk A M T²^ORCID,Fischer Kathelijn³,Kshirsagar Shrinath¹^ORCID,Rangarajan Savita¹,Phadke Varsha¹,Mhatre Shrutika¹,Sontate Bharati¹,silva Magdelene D’¹,Ansari Shahana¹,Shetty Shrimati¹^ORCID

Affiliation:

1. Advanced Center for Oncology Haematology & Rare Disorders (ACOHRD) K. J. Somaiya Medical College & Research Center Somaiya Ayurvihar Mumbai Maharashtra India

2. Department of Clinical Pharmacy University Medical Center Utrecht Utrecht University Utrecht The Netherlands

3. Center for Benign Haematology Thrombosis and Haemostasis, Van Creveldkliniek University Medical Center Utrecht Utrecht University Utrecht The Netherlands

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14785

Reference10 articles.

1. Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens

2. Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors

3. Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study

4. European Medicines Agency 2011 Guideline on Bioanalytical Method Validation

5. Hemophilia trials in the twenty-first century: Defining patient important outcomes

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center;Pediatric Investigation;2024-07-22

2. Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China;Haemophilia;2024-06-09

3. Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab;Cureus;2024-04-24

4. Lower-dose emicizumab prophylaxis: can less be more?;Journal of Thrombosis and Haemostasis;2024-04

5. Haemophilia care in Asia: Learning from clinical practice in some Asian countries;Haemophilia;2024-03-24